Nitrogen

Description

No description information is available for the specified drug.

Uses and Indications

Nitrogen, Compressed NF is classified as a medical gas and is indicated for various medical applications. This drug is utilized in clinical settings where the use of a compressed gas is necessary for therapeutic purposes.

There are no teratogenic or nonteratogenic effects associated with the use of Nitrogen, Compressed NF.

Dosage and Administration

Administration of Nitrogen is indicated via the respiratory route through inhalation. The active ingredient consists of Nitrogen at a concentration of 99 liters in 100 liters.

Due to the potential hazards associated with the use of Nitrogen, it is imperative that administration is conducted only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of this gas. Healthcare professionals should ensure that all safety protocols are followed during the administration process to mitigate any risks associated with its use.

Contraindications

Use of this product is contraindicated until all safety precautions have been read and understood. Failure to adhere to this guideline may result in improper handling and potential safety risks.

Warnings and Precautions

Administration of Nitrogen may pose significant risks and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses expertise in the use and administration of Nitrogen. This includes a thorough understanding of its indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

The product contains gas under pressure, which presents a risk of explosion if subjected to heat. Additionally, Nitrogen may displace oxygen in the environment, leading to rapid suffocation. Therefore, it is crucial to read and comprehend all safety precautions prior to handling. Nitrogen should only be used and stored outdoors or in well-ventilated areas. A backflow preventive device must be utilized in the piping system, and equipment must be rated for cylinder pressure. The valve should be closed after each use and when the cylinder is empty. Furthermore, protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). Healthcare professionals are advised to consult and adhere to the Safety Data Sheet (SDS) before use.

In the event of inhalation, it is essential to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice or attention should be sought immediately.

Side Effects

Administration of Nitrogen may pose significant risks and is contraindicated in certain situations. It is essential that it be used only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Serious warnings associated with Nitrogen include the presence of gas under pressure, which may lead to explosion if heated. Additionally, Nitrogen can displace oxygen, resulting in rapid suffocation. Therefore, it is critical to adhere to all safety precautions prior to handling. Nitrogen should only be used and stored outdoors or in well-ventilated areas. A backflow preventive device must be utilized in the piping, and equipment rated for cylinder pressure should be employed. Users are advised to close the valve after each use and when the cylinder is empty, and to protect the cylinder from sunlight when ambient temperatures exceed 52°C (125°F). It is imperative to read and follow the Safety Data Sheet (SDS) before use.

In the event of inhalation, immediate first aid measures should be taken. The affected individual should be removed to fresh air and kept comfortable for breathing. Medical advice or attention should be sought promptly.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety and efficacy of this drug during pregnancy have not been established, as it has not been approved by the FDA. The administration of Nitrogen may pose potential hazards or contraindications, and therefore, it is recommended that this drug be used only by or under the supervision of a licensed practitioner experienced in its use and administration.

Due to the lack of specific data regarding the use of Nitrogen in pregnant patients, including safety concerns, dosage modifications, or special precautions, healthcare professionals should exercise caution when considering this drug for women of childbearing potential. It is essential to weigh the potential risks against the benefits in this population.

Lactation

No specific information regarding the use of Nitrogen, compressed, in lactating mothers or its effects on breastfed infants is provided in the drug insert. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is crucial. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical status. Monitor for any signs of toxicity or adverse reactions.

2. Supportive Care: Provide supportive care as needed, which may include airway management, oxygen supplementation, intravenous fluids, and monitoring in a controlled environment.

3. Decontamination: If the overdose is recent and the patient is alert and able to protect their airway, consider activated charcoal administration to limit further absorption of the substance.

4. Consultation: Engage with a poison control center or toxicology expert for guidance on specific management strategies tailored to the substance involved.

5. Documentation: Ensure that all findings, interventions, and patient responses are thoroughly documented in the medical record.

It is imperative for healthcare professionals to familiarize themselves with the specific management protocols for the substances they encounter, as well as to stay updated on any emerging guidelines related to overdose treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must emphasize the warning that Nitrogen contains gas under pressure, which may explode if heated. Patients should be made aware that Nitrogen can displace oxygen and lead to rapid suffocation. It is crucial that patients do not handle Nitrogen until they have read and understood all safety precautions. They should be instructed to use and store Nitrogen only outdoors or in a well-ventilated area. The use of a backflow preventive device in the piping is recommended, and equipment must be rated for cylinder pressure. Patients should be reminded to close the valve after each use and when the cylinder is empty, and to protect the cylinder from sunlight when the ambient temperature exceeds 52°C (125°F). Providers should encourage patients to read and follow the Safety Data Sheet (SDS) prior to use.

In the event of inhalation, healthcare providers should instruct patients to remove the affected individual to fresh air and ensure they remain comfortable for breathing. It is important to seek medical advice or attention promptly.

Storage and Handling

The product is supplied in a configuration suitable for outdoor use or in well-ventilated areas. It is essential to protect the product from sunlight when the ambient temperature exceeds 52°C (125°F).

Users are advised to close the valve after each use and when the cylinder is empty. Additionally, a backflow preventive device must be utilized in the piping to ensure safety. It is crucial to use the product only with equipment that is rated for cylinder pressure.

Before handling the product, all safety precautions must be thoroughly read and understood to ensure safe usage.

Additional Clinical Information

No further data are available.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Messer Gas Puerto Rico, Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)